Actively Recruiting

Phase Not Applicable
Age: 8Years - 18Years
All Genders
ID07302295

Clinical and Socioeconomic Characteristics of Suicidal Behaviour in Children and Adolescents During the Covid19 Pandemic Period in Auvergne-Rhône-Alpes. Prospective Quantitative and Qualitative Study

Led by Hospices Civils de Lyon · Updated on 2026-05-18

6500

Participants Needed

4

Research Sites

13 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research investigates the clinical and socioeconomic characteristics of children and adolescents who experienced suicidal behavior in the Auvergne Rhone Alpes region during the COVID-19 pandemic. It focuses on the impact of social restrictions and eco-anxiety during the pandemic on suicidal behavior, especially among those aged 8 to under 18 years. The study compares data from the pandemic period with data from before the pandemic to better understand changes in suicidal behaviors and psychological conditions. Participants are grouped into those with suicidal behaviors during the COVID-19 crisis between 2020 and 2022, including a subgroup involved in qualitative interviews with their parents, and a control group with similar behaviors before the pandemic from 2018 to 2019. Data collection includes aggregated demographic and diagnostic information from hospital records, as well as detailed socioeconomic and psychopathological data. Some participants and their parents will also take part in interviews and focus groups. Throughout the study, researchers will collect baseline demographic and diagnostic data, and follow up with assessments including psychological scales and qualitative interviews up to three months. The study tracks the number of patients admitted for suicidal behaviors and evaluates psychological impact through specific scales and interviews. Participation may last up to several months, with data collected via hospital records, interviews, and questionnaires to understand the factors influencing suicidal behavior during and before the pandemic.

CONDITIONS

Brief Title

Analysis of Suicidal Behavior Among Children and Adolescents in the Auvergne-Rhone-Alpes Region During the Covid 19 Pandemic Period

Who Can Participate

Age: 8Years - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Children and adolescents aged 8 to under 18 years
  • Admitted to pediatric emergency or hospitalized in the Auvergne Rhone Alpes region for suicidal behavior during 2020-2022 (Group 1 and 1b) or during 2018-2019 (Group 2)
  • Suicidal behavior defined as suicidal ideation, suicide attempt, or self-harm/self-poisoning with suicidal intent
  • Participants for qualitative interviews must have signed informed consent along with their parents for Group 1b
  • Participants divided into age categories: pre-adolescents (8 to <11 years), adolescents (11 to <15 years), older adolescents (15 to <18 years)
Not Eligible

You will not qualify if you...

  • Admission for psychiatric reasons other than suicidal behavior during the study periods for each group
  • Intercurrent illness with life expectancy less than 24 hours (Group 2)
  • Pregnant, postpartum, or breastfeeding females (Group 1)
  • Persons deprived of liberty by judicial or administrative decision (Group 1)
  • Adults under legal protection measures (guardianship, curatorship) (Group 1)
  • Persons not affiliated with a social security scheme or similar (Group 1)
  • Persons who do not understand or speak French (Group 1)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote) for consent and eligibility assessment

Data Collection and Qualitative Interview

Duration - Up to 3 months

Participants provide demographic, diagnostic, psychopathological, and socioeconomic information. Those who agree participate in interviews and/or focus groups along with their parents.

1 to 2 visits depending on participation in interviews and focus groups

Trial Site Locations

Total: 4 locations

1

Hospices Civils de Lyon - Hôpital Femme Mère Enfant- Service de pédopsychiatrie de l'enfant et de l'adolescent

Bron, France, 69500

Actively Recruiting

2

CHU de Clermont-Ferrand - Service de psychiatrie de l'enfant et de l'adolescent

Clermont-Ferrand, France, 63000

Not Yet Recruiting

3

CHU de Grenoble - Service de psychiatrie de l'enfant et de l'adolescent

Grenoble, France, 38043

Not Yet Recruiting

4

CHU de Saint-Etienne - Urgences psychiatriques

Saint-Etienne, France, 42100

Not Yet Recruiting

Loading map...

Research Team

E

Elise MAMIMOUE, Dr

S

Sonia GALLETTI

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

3

Similar Trials

Acceptability & Safety of Two Sequential Doses of Psilocybin...

Bipolar II Disorder

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here